Related Experiment Video
Updated: Nov 15, 2025

09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.3K
Do Outcomes between Women and Men Differ after Endovascular Thrombectomy? A Meta-analysis
A A Dmytriw1, J C Ku2, V X D Yang2
1Department of Medical Imaging (A.A.D., T.R.M., J.D.B.D.), University of Toronto, Toronto, Ontario, Canada admytriw@bwh.harvard.edu.
AJNR. American Journal of Neuroradiology
|March 5, 2021
Summary
Men had better outcomes after endovascular thrombectomy for acute ischemic stroke. This study found women experienced inferior 90-day clinical outcomes, highlighting the need for sex-specific research in stroke treatment.
Area of Science:
- Neurology
- Interventional Cardiology
- Public Health
Background:
- Existing research on sex-based differences in endovascular thrombectomy outcomes for acute ischemic stroke presents conflicting findings.
- Understanding these differences is crucial for optimizing stroke treatment strategies.
Purpose of the Study:
- To systematically investigate whether sex influences patient outcomes following endovascular thrombectomy for large-vessel occlusion stroke.
- To provide a comprehensive analysis of sex-specific results in stroke intervention.
Main Methods:
- A systematic review and meta-analysis of 33 studies involving 7335 patients undergoing endovascular thrombectomy.
- Pooled analysis of outcomes including 90-day modified Rankin Scale score, mortality, symptomatic intracranial hemorrhage, and recanalization, stratified by sex.
Main Results:
- Men demonstrated significantly better 90-day functional outcomes (modified Rankin Scale score ≤ 2) compared to women (OR = 1.29; P < .001).
- No significant sex-based differences were observed in 90-day mortality, symptomatic intracranial hemorrhage, or recanalization rates.
- Moderate heterogeneity was noted, with most included studies being retrospective.
Conclusions:
- Women undergoing endovascular thrombectomy for large-vessel occlusion stroke experience poorer 90-day clinical outcomes.
- Further research, including sex-specific clinical trials and pathophysiological studies, is warranted to explore these disparities.

